Pacira Biosciences
PCRX
Pacira Biosciences (PCRX) - Total liabilities
Total liabilities on the balance sheet as of December 2023 : $0.70 B
According to Pacira Biosciences 's latest financial reports the company's total liabilities are $0.70 B. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Pacira Biosciences - Total liabilities on balance sheet (from 2009 to 2023)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2023-12-31 | $0.70 B | -22.28% |
| 2022-12-31 | $0.90 B | -32.62% |
| 2021-12-31 | $1.34 B | 105.39% |
| 2020-12-31 | $0.65 B | 37.53% |
| 2019-12-31 | $0.47 B | 29.34% |
| 2018-12-31 | $0.36 B | 5.51% |
| 2017-12-31 | $0.34 B | 102.27% |
| 2016-12-31 | $0.17 B | 1.86% |
| 2015-12-31 | $0.16 B | 9.31% |
| 2014-12-31 | $0.15 B | 20.5% |
| 2013-12-31 | $0.12 B | 178.3% |
| 2012-12-31 | $46.19 M | -29.17% |
| 2011-12-31 | $65.22 M | -43.26% |
| 2010-12-31 | $0.11 B | 71.81% |
| 2009-12-31 | $66.9 M | 55.4% |
| 2008-12-31 | $43.05 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Omeros Corporation OMER | $0.50 B | -28.01% | 🇺🇸 USA |
 Heron Therapeutics HRTX | $0.25 B | -63.58% | 🇺🇸 USA |
 Cara Therapeutics
CARA | $68.75 M | -90.24% | 🇺🇸 USA |